Related Experiment Video

Updated: Jan 29, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

380

Paving the way for targeting RSK in cancer

Yves Romeo1, Philippe P Roux

  • 1Institute for Research in Immunology and Cancer, Université de Montréal, Station Centre-Ville, QC, Canada.

Expert Opinion on Therapeutic Targets
|October 21, 2010
PubMed

Insights

The 90 kDa ribosomal S6 kinase (RSK) family regulates cell growth and survival. Targeting RSK offers a promising therapeutic strategy for cancers driven by Ras signaling pathway mutations.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • The 90 kDa ribosomal S6 kinase (RSK) family are key regulators of cell proliferation, growth, motility, and survival.
  • Aberrant RSK activity is implicated in various human diseases, notably cancer.
  • RSK functions downstream of the Ras/mitogen-activated protein kinase (MAPK) pathway, activated by ERK1/2.

Purpose of the Study:

  • To review current knowledge on RSK's role in cell growth and proliferation.
  • To explore RSK-dependent mechanisms driving tumorigenesis.
  • To discuss the therapeutic potential of targeting RSK in cancer treatment.

Main Methods:

  • Literature review of recent advances in RSK signaling research.
  • Analysis of RSK's impact on cellular processes and tumor development.
  • Evaluation of RSK family members' biological functions and targeting strategies.

Main Results:

  • Recent research has identified novel RSK substrates, functions, and regulatory mechanisms.
  • RSK signaling pathways are crucial for cell growth, proliferation, and survival.
  • Deregulated RSK is linked to oncogenesis, particularly in Ras-mutated cancers.

Conclusions:

  • RSK is a significant factor in cancer development and progression.
  • Targeting RSK, especially with small molecule inhibitors, presents a promising avenue for cancer therapy.
  • Further evaluation of RSK inhibitors and their clinical application is warranted.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

11.8K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.2K
Masonry Paving01:21

Masonry Paving

The construction of masonry paving involves using materials such as bricks, stones, and concrete masonry units. These materials are chosen for their shape, color, strength, and resistance to abrasion and weathering. Masonry units can be installed dry on a thin layer of sand and a gravel base, or they can be embedded in mortar or asphalt on a concrete slab. For areas subjected to heavy vehicular loads, a rigid base layer of reinforced or unreinforced concrete is recommended. In contrast,...
513
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.0K